Risk Management in Clinical Research

Ensure your clinical trials comply with the latest focus on GCP inspections and develop your own quality risk management principles and procedures

24 Sep 2018

GBP 699
EUR 979
USD 1,090

Book now

Why you should attend?

Risk management is becoming increasingly important to running clinical trials. There are now numerous pharmaceutical guidelines covering risk management including ICH Q9, the revised ICH GCP R2 guideline, the revised EU Clinical Trial Regulation guideline on risk management and several other risk management clinical research standards and initiatives.

This essential one day course will explain the importance of using risk management techniques in clinical research to comply with the latest focus on GCP inspection in this area. It will show you how risk management can improve the quality of your clinical trials and demonstrate the importance of using risk analysis and risk management techniques in clinical trials. You will learn how to identify, evaluate and also how to implement specific risk-based techniques for risk management used in clinical trials.

Who should attend?

Anyone working on clinical trials including CRAs, monitors, clinical managers, project managers, lead clinical research associates, data managers and statisticians, study managers, quality assurance/audit and QC, document management. It will also be relevant to those who work alongside the study team, such as regulatory affairs.


An overview of risk management

  • Why risk management is important?
  • Definitions of key risk management terminology
  • Regulations and guidelines which cover risk management applied to clinical study-level risk management

Risk-based QM system – what does this really mean? How does it look?

  • What are the elements of QM system and what a regulatory inspector would expect to be in place for clinical trials
  • Group discussion – participants share what systems they have in place

Risk-based process/tools and techniques

  • Examples of risk management process
  • Risk-based tools including
    • Root cause analysis – 5 Whys
    • Risk register
    • Risk matrix
    • Examples of pharmaceutical risk tools for clinical trials including RACT (Risk Assessment Categorization Tool)

Risk-based approach to the protocol

  • Quality by design (QbD) applied to the protocol
  • How this is being applied to the design of protocols

Risk-based approach to monitoring/data handling

  • Different approaches to risk-based monitoring and examples of how this is carried out – eg of a risk-based monitoring plan
  • Discussion of what approaches and documents are used
  • Case study example

Brief review of risk-based approaches to QC/QA (Auditing)

  • Example of best practice guide RQA (Research Quality Association)

Final Discussion

Continuing professional development

This course qualifies for the following CPD programmes:

  • CPD certificate of attendance

Book now

24 Sep 2018
24 Sep 2018 Rembrandt Hotel, London GBP 699.00
EUR 979.00
USD 1,090.00
+ VAT @ 20.00%
Enrol now

Previous customers include...

  • ADAMAS Consulting
  • Bracco Imaging S.p.A.
  • Cancer Research UK
  • Dermal Laboratories Ltd
  • GE Healthcare Ltd
  • Laboratoires SMB
  • Leo-Pharma A/S
  • ObsEva Sa
  • Sanofi Aventis Recherche & Développement
  • Summit Therapeutics